June 3, 2020
Octapharma USA Extends Funding for COVID-19 Study Following Positive Preliminary Research Data
Octapharma USA Extends Funding for COVID-19 Study Following Positive Preliminary Research Data
Pharmaceuticals, Biotechnology and Life Sciences
Octapharma USA Extends Funding for COVID-19 Study Following Positive Preliminary Research Data
Phase 3, multicenter U.S. clinical trial utilizing Octagam® 10% will start immediately to evaluate if high-dose IVIG can stabilize or…